Published in BMJ on January 16, 1999
A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med (1997) 24.87
BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax (1997) 9.69
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med (1997) 8.48
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group. N Engl J Med (1998) 7.08
Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med (1997) 6.09
Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ (1998) 6.07
A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med (1996) 4.70
Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med (1996) 4.10
The use of induced sputum to investigate airway inflammation. Thorax (1997) 3.85
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. Lancet (1998) 3.56
Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med (1997) 3.31
Incidence of community-acquired pneumonia in the population of four municipalities in eastern Finland. Am J Epidemiol (1993) 2.90
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med (1997) 2.77
Cost-effectiveness of the transdermal nicotine patch as an adjunct to physicians' smoking cessation counseling. JAMA (1996) 2.69
One year treatment with salmeterol compared with beclomethasone in children with asthma. The Dutch Paediatric Asthma Study Group. Am J Respir Crit Care Med (1997) 2.16
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis. Am J Respir Crit Care Med (1996) 2.14
A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire. N Engl J Med (1997) 1.97
Corticosteroid reversibility in COPD is related to features of asthma. Am J Respir Crit Care Med (1997) 1.87
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. N Engl J Med (1997) 1.84
Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people. JAMA (1997) 1.74
Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'. Arch Intern Med (1997) 1.62
The effect of a peak flow-based action plan in the prevention of exacerbations of asthma. Chest (1997) 1.61
Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. The Columbus Investigators. N Engl J Med (1997) 1.54
Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med (1997) 1.50
Observations on asthma mortality. Ann Intern Med (1997) 1.48
Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data. Am J Respir Crit Care Med (1997) 1.44
Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med (1996) 1.41
A cost-effectiveness analysis of directly observed therapy vs self-administered therapy for treatment of tuberculosis. Chest (1997) 1.32
The clinical validity of normal compression ultrasonography in outpatients suspected of having deep venous thrombosis. Ann Intern Med (1998) 1.23
Lung-volume reduction improves dyspnea, dynamic hyperinflation, and respiratory muscle function. Am J Respir Crit Care Med (1997) 1.21
A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med (1998) 1.16
D-dimer testing for suspected pulmonary embolism in outpatients. Am J Respir Crit Care Med (1997) 1.14
The use of D-dimer testing and impedance plethysmographic examination in patients with clinical indications of deep vein thrombosis. Arch Intern Med (1997) 1.11
The role of leukotriene modifiers in the treatment of asthma. Am J Respir Crit Care Med (1998) 1.11
Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med (1997) 1.04
Preoperative predictors of operative morbidity and mortality in COPD patients undergoing bilateral lung volume reduction surgery. Chest (1997) 1.00
Selection criteria and programmes for pulmonary rehabilitation in COPD patients. Rehabilitation and Chronic Care Scientific Group of the European Respiratory Society. Eur Respir J (1997) 0.99
Lung volume reduction surgery for emphysema. Eur Respir J (1997) 0.91
Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. The American Academy of Allergy, Asthma and Immunology Beclomethasone Dipropionate-Theophylline Study Group. J Allergy Clin Immunol (1998) 0.90
Salmeterol reduces dyspnea and improves lung function in patients with COPD. Chest (1997) 0.85
Thoracoscopic lung volume reduction surgery reduces dyspnea and improves exercise capacity in patients with emphysema. Am J Respir Crit Care Med (1997) 0.84
Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function. Eur Respir J (1996) 0.84
Peripheral blood markers: evaluation of inflammation in asthma. Eur Respir J Suppl (1998) 0.82
Exhaled nitric oxide as a marker in asthma. Eur Respir J Suppl (1998) 0.81
Exercise training in COPD patients: the basic questions. Eur Respir J (1997) 0.79
Changes in ventilatory mechanics and diaphragmatic function after lung volume reduction surgery in patients with COPD. Thorax (1997) 0.78